EcoDrugPlus

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSCPOG00000006114
Gene Symbol: PSMA3
2 Cross references
247 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSCPOG00000019698
Gene Symbol: PSMA4
4 Cross references
249 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSCPOG00000013670
Gene Symbol: PSMA5
4 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSCPOG00000003107
Gene Symbol: PSMA6
4 Cross references
287 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSCPOG00000014168
Gene Symbol: PSMA7
2 Cross references
152 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSCPOG00000012268
Gene Symbol: PSMA8
4 Cross references
198 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSCPOG00000001187
Gene Symbol: PSMB1
2 Cross references
217 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSCPOG00000021270
Gene Symbol: PSMB10
2 Cross references
172 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSCPOG00000036531
Gene Symbol: PSMB2
2 Cross references
220 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSCPOG00000025974
Gene Symbol: PSMB3
4 Cross references
258 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSCPOG00000015209
Gene Symbol: PSMB4
2 Cross references
214 Possible Orthologues:

Proteasome 20s Subunit Beta 5

Ensembl ID : ENSCPOG00000014047
Gene Symbol: PSMB5
2 Cross references
219 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).